biomedicina slovenica

pr=Chalofti : 1

1. Čufer T; Lazarev A; El-Ghamrawy K; Doval D; Vrba Z; Shah P; Kurtova A; Ghilezan N; Chalofti I; Blanc C
   Preliminary data of a phase II trial of taxotere (TXT) 100 or 75 mg/m2 as 2nd line chemotherapy (CT) in patients (pts) with metastatic breast cancer (MBC) with stratification according to prognosis factors
   1998 ►

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics